This is the new MLex platform. Existing customers should continue to use the existing MLex platform until migrated.
For any queries, please contact Customer Services or your Account Manager. Dismiss

Cognizant seeks dismissal of Infosys' antitrust counterclaim in US court

( April 14, 2025, 21:43 GMT | Official Statement) -- MLex Summary: Cognizant has asked a US court to dismiss Infosys' antitrust claims. The US tech giant has argued that the Indian software company lacks sufficient evidence. It claimed that Infosys allegedly failed to define product markets and did not show Cognizant's monopoly power, according to a filing made to the United States District Court for the Northern District of Texas, Dallas Division. Infosys also did not prove exclusionary conduct or antitrust injury, the document claimed, asking the court to dismiss Infosys' claims. This development follows an ongoing legal battle that began in August 2024 as a trade secret suit between the two tech rivals filed in the US and has now expanded to include antitrust issues. The document filed to the United States District Court for the Northern District of Texas, Dallas Division, is attached....

Prepare for tomorrow’s regulatory change, today

MLex identifies risk to business wherever it emerges, with specialist reporters across the globe providing exclusive news and deep-dive analysis on the proposals, probes, enforcement actions and rulings that matter to your organization and clients, now and in the longer term.


Know what others in the room don’t, with features including:

  • Daily newsletters for Antitrust, M&A, Trade, Data Privacy & Security, Technology, AI and more
  • Custom alerts on specific filters including geographies, industries, topics and companies to suit your practice needs
  • Predictive analysis from expert journalists across North America, the UK and Europe, Latin America and Asia-Pacific
  • Curated case files bringing together news, analysis and source documents in a single timeline

Experience MLex today with a 14-day free trial.

Start Free Trial

Already a subscriber? Click here to login

Documents

Related Sections